GlassScriptPhysician profile
Joseph A Cartwright
NPI 1265659460
$17,850.16
in general payments reported to CMS, 2019-2025
60 companies · $2,952 in 2025
The $2,952 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,033 · 2020: $1,006 · 2021: $2,784 · 2022: $3,602 · 2023: $2,918 · 2024: $2,555 · 2025: $2,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,183 · Travel and Lodging: $226 · Education: $16.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,182.98 |
| Travel and Lodging | $225.87 |
| Education | $16.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,937.84 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Abbvie INC. | $1,903.27 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Nevro Corp. | $1,207.23 | 2019-2024 | Senza |
| Relievant Medsystems, INC. | $751.44 | 2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $693.85 | 2019-2025 | Relistor |
| Abbott Laboratories | $477.23 | 2020-2025 | Eterna |
| Medtronic, INC. | $473.28 | 2021-2025 | Intellis Adaptivestim, Cd Horizon Spinal System, Synchromedii |
| Collegium Pharmaceutical, INC. | $457.20 | 2019-2025 | Xtampza, Belbuca |
| Spr Therapeutics, INC | $376.34 | 2019-2025 | Sprint Pns System |
| Pfizer INC. | $373.17 | 2019-2025 | |
| Amgen INC. | $354.56 | 2019-2022 | |
| Stimwave Technologies Incorporated | $235.59 | 2019-2022 | |
| Curonix LLC | $227.38 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biohaven Pharmaceuticals, INC. | $225.75 | 2020-2021 | |
| Flowonix Medical Incorporated | $221.32 | 2019-2020 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cartwright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.